Veritable, L.P. Maravai Lifesciences Holdings, Inc. Transaction History

Veritable, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$20.6 - $30.37 $79,474 - $117,167	-3,858 Reduced 24.52%	11,875 $303,000
Q2 2022 Aug 15, 2022	BUY	$26.05 - $37.48 $11,227 - $16,153	431 Added 2.82%	15,733 $447,000
Q1 2022 May 11, 2022	SELL	$24.46 - $40.92 $5,381 - $9,002	-220 Reduced 1.42%	15,302 $540,000
Q4 2021 Feb 14, 2022	BUY	$35.0 - $45.94 $165,550 - $217,296	4,730 Added 43.83%	15,522 $650,000
Q3 2021 Nov 15, 2021	BUY	$36.8 - $60.62 $191,507 - $315,466	5,204 Added 93.13%	10,792 $530,000
Q2 2021 Aug 16, 2021	BUY	$32.46 - $45.0 $181,386 - $251,460	5,588 New	5,588 $233,000

234

140M

223K

19.4K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $723M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Veritable, L.P., based on Form 13F filings with the SEC.

Stay updated on Veritable, L.P. with notifications on news.